Optimal activation of tumour-antigen-specific T cells overexpressing IL-4R–IL-7R CSRs occurred only when engineered T cells encountered their specific tumour antigen and elevated IL-4 was present in the tumour microenvironment. Here, IL4 is linked to neoplasm.